NKGN: NKGen Biotech Corp Narxning sof foyda o‘sishiga nisbati
NKGen Biotech, Inc. (NKGN) neyrodegeneratsiyaga qarshi hujayra terapiyasi portfelini kengaytirishning boshlang‘ich nuqtasida turibdi. Baholashning o‘sishga nisbati joriy dinamikani aks ettiradi va ushbu ko‘rsatkich qiymati 0.00 ni tashkil etadi. Aksiyalar narxi Altsgeymer va Parkinson kasalliklariga qarshi NK hujayralarining sinov natijalariga, shuningdek, sterillikni va dori ishlab chiqarishning kengaytirilishini ta’minlovchi robotlashtirilgan ishlab chiqarishga bog‘liq.
NKGen Biotech, Inc. (NKGN) kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati NKGen Biotech, Inc.|NKGN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati nkgenbiotech.com|NKGN - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar NKGen|NKGN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz NKGen Biotech|Oraliq likvidlik koeffitsiyenti nkgenbiotech.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
NKGN - Sof foyda|Kutilayotgan sof foyda NKGen Biotech, Inc.|NKGN - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati NKGen Biotech Corp|NKGN - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati NKGen|NKGN - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda NKGen Biotech|NKGN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi nkgenbiotech.com|NKGN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati NKGen Biotech, Inc.
Kompaniyaning umumiy tahlili:NKGN, NKGen Biotech Inc
NKGen Biotech, Inc. (NKGN) klinik sinovlar uchun kapitalga muhtoj, shu sababli PEG koeffitsiyenti foydaga nisbatan xarajatlar samaradorligini tahlil qilish uchun muhim vositaga aylanadi. Ushbu metrika joriy P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymatlar aktivning fundamental tarzda qadrsizlanganligidan dalolat beradi va investorlarga haqiqiy kengayish potentsialini kassa oqimi yetishmovchiliklari xavflaridan ajratish imkonini beradi.
NKGen Biotech, Inc. raqobatchilari
PEG multiplikatori Biogen Inc (BIIB)|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|Narxning sof foyda o‘sishiga nisbati Regencell Corp|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narx-foyda va o‘sish multiplikatori SUPN|CPRX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori DNLI|Narxning foydaga va o‘sish sur’atiga nisbati HRMY (harmonybiosciences.com)|PEG multiplikatori BHVN (Biohaven)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Amylyx Pharmaceuticals Inc (AMLX)|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Praxis Corp|AVXL (Anavex Life Sciences) - Narx-foyda va o‘sish multiplikatori|CBLL: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PRTA (Prothena Corporation plc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alector Therapeutics ALEC|PEG multiplikatori ANNX|Narx-foyda va o‘sish multiplikatori omeros.com OMER|PEG multiplikatori NGNE (Neurogene Inc.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|VYGR: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NMRA (Neumora)|SCLX: PEG multiplikatori|TVGN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Alpha Cognition Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CGTX (cogrx.com)|PEG multiplikatori IKT|Narx-foyda va o‘sish multiplikatori Cassava Sciences Inc SAVA|Assertio - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VTGN - Narxning foydaga va o‘sish sur’atiga nisbati|OVID (Ovid Therapeutics Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Acumen Pharmaceuticals, Inc. (ABOS) - Narxning foydaga va o‘sish sur’atiga nisbati|CervoMed, Inc. (CRVO) - PEG multiplikatori|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|CLNN - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|jupiterneurosciences.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Grace Tx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Firefly Neuro|KLTO (anewmeds.com) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics Ltd. (NRSN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|MTVA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|HSDT - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Passage Bio PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|ATHA - PEG multiplikatori|ADXN: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Alzamend Neuro ALZN|CYCN (Cyclerion Therapeutics Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Protagenic PTIX|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|cortigent.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Avenue Therapeutics, Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BCLI|Cara Therapeutics, Inc. - PEG multiplikatori|CHRO: Narxning foydaga va o‘sish sur’atiga nisbati|ELYM: PEG multiplikatori|ITCI - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Longboard Pharma|O‘sish sur’atiga tuzatilgan narx-foyda Marinus Pharma MRNS|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|PEG multiplikatori SNPX (Synaptogenix)|Trevena Inc. (TRVN) - O‘sish sur’atiga tuzatilgan narx-foyda|Vigil Neuro - PEG multiplikatori|Anew Medical Inc. (WENA) - Narx-foyda va o‘sish multiplikatori|CERE: PEG multiplikatori
